FDA-Drug2014-03-26Class I
Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
Fabscout Entertainment, Inc
Hazard
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
Sold states
Nationwide and France
Manufactured in
1458 NW 23rd Ave, Ft Lauderdale, FL, United States
Products
Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1169-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief